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BACKGROUND/PURPOSE: The re-emergence of an epidemic strain of dengue virus type-3 (DENV-3) 
in Delhi in 2003 and its persistence in subsequent years marked a changing trend in dengue virus circula-
tion in this part of India. Its evolving phylogeny over the past decade has not been studied in detail as yet.
METHODS: Reverse transcription polymerase chain reaction and sequencing of the CprM gene junction 
of DENV-3 from different outbreaks since 2003 was carried out. Thirty CprM DENV-3 sequences from 
this study were compared with 46 other previously reported CprM DENV-3 sequences from India and 
other countries. Multiple sequence alignment and phylogenetic trees were constructed to determine the 
extent of genetic heterogeneity and trace the phylogeny of DENV-3.
RESULTS: Thirty CprM DENV-3 sequences (Accession numbers AY706096–99, DQ645945–52, 
EU181201–14, and EU846234–36) were submitted to GenBank. The CprM junction was found to be AT 
rich (approximately 53%). Nucleotide sequence alignment revealed only nucleotide substitutions. Phyloge-
netic analysis indicated sustained evolution of a distinct Indian lineage of DENV-3 genotype III in Delhi.
CONCLUSION: Active circulation of DENV-3 genotype III over the last decade in Delhi was evident and 
worrying. This genotype has been implicated in several outbreaks in South-East Asia and other parts of 
the world.
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Introduction
The re-emergence of dengue virus infection is assuming 
epidemic proportions in various parts of the world, and at 
a greater frequency than previously experienced.1–5 The 
first recorded epidemic of dengue fever (DF), also known as 
dengue hemorrhagic fever (DHF), in the Asian subcontinent 
occurred during the 1950s. Almost 30 years later, it ap-
peared in the Americas for the first time.6,7 Coincidentally, 
several outbreaks of DF were also reported in different 
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parts of India during the same period.8–11 The metropoli-
tan city of Delhi reports approximately 33% of the total 
yearly cases reported in India.12 Delhi has a humid, mon-
soon influenced subtropical climate with daily temper-
atures ranging from 25–30°C, providing a conducive 
environment for Aedes mosquito breeding. The other fac-
tors that contribute to an increased population of the dis-
ease transmitting arthropod vector, Aedes aegypti, are rapid 
urbanization, water storage practices and the use of water 
coolers among the general population. During the post-
monsoon season, the mosquito vector thrives well and 
transmits dengue virus amongst the human population 
which sometimes giving rise to a major outbreak depending 
on the prevalent genotype of dengue virus or its serotype.
Delhi experienced its first major DF outbreak in 1996, 
during which we observed complete replacement of the 
genotype V Dengue virus type (DENV)-2 by a more viru-
lent genotype IV DENV-2.4 Vigilance over the following 
years confirmed a continued dominance of this DENV-2 
genotype, similar to the FJ 10/11 strain in China, in Delhi 
and adjoining Northern India until the end of 2002.13 
During a major DF outbreak in 2003, we suddenly ob-
served a re-emergence and abundance of DENV-3 con-
taining close sequence identity with a strain isolated in 
Guatemala in 1998.14 The magnitude of the DF outbreak 
during 2004 was relatively low, but a study by Dash et al15 
of six isolates from the 2004 outbreak confirmed circula-
tion of similar strains of DENV-3 in Delhi. Active circula-
tion of this virus continued throughout 2005 and by the 
post-monsoon period of 2006, the whole of northern 
India including Delhi again witnessed a large-scale out-
break of DF in which DENV-3 was implicated in approxi-
mately 70% of cases and DENV-1 in approximately 30% of 
cases studied.16 In 2007, despite there having been DF 
outbreak, circulation of DENV-3 was confirmed by detec-
tion of three DENV-3 isolates from Delhi, and two iso-
lates of DENV-1 were reported by us.17 No DENV-3 
isolates were detected in 2008. In spite of these sporadic 
observations on a limited number of samples indicating 
active circulation of DENV-3 in this part of India, the 
exact trends of viral evolution in terms of genetic hetero-
geneity over the current decade is not clearly understood. 
Genotyping of DENV-3 has been performed previously 
with the CprM junction most widely used in the genotyp-
ing of Indian dengue isolates.18,19 The D1 and D2 primer 
pair reported by Lanciotti et al in 1992 are capable of am-
plifying a 511-bp region of the CprM in all four types of 
dengue viruses.20 The usefulness of this CprM junction for 
carrying out subtyping of dengue viruses has been estab-
lished by us and other workers.13,15,16,21,22
The present study was designed to elucidate the nucle-
otide sequence diversity in the CprM gene junction of 
dengue virus and to determine the phylogeny of DENV-3 
that has persistently circulated in Delhi since its re-
emergence in 2003.
Materials and methods
Clinical samples
Approval of the institutional ethical committee was ob-
tained to carry out the present study. Acute phase serum 
samples were collected from suspected clinical cases of DF 
from different geographical locations in Delhi. Samples 
were collected during the post-monsoon season each year 
from 2003. Informed consent from all patients was ob-
tained before collection of clinical samples.
RNA extraction
Viral RNA was isolated from 140 μL of serum samples or 
culture supernatant using a QIAamp Viral RNA Mini kit 
(Qiagen, Hidden, Germany) according to manufacturer’s 
protocol. Final elution was done in 50 μL of diethyl pyro-
carbonate-treated water before storing at –80°C until use.
cDNA synthesis and amplification of CprM junction
Reverse transcription polymerase chain reaction (RT-PCR) 
was carried out as described previously16 using the CprM 
gene-specific primers, D1 and D2, which amplified a 511-bp 
amplicon as reported by Lanciotti et al.20 Briefly, cDNA 
was synthesized in a 10 μL reaction volume comprising 
5 × RT buffer, 10 mM dNTPs, 100 mM DTT, 20 U RNase 
inhibitor and 50 U MultiScribeTM RT (Applied Biosystems, 
Foster City, CA, USA) with 2 pmols of D2 primer. The RT 
mix was incubated at 42°C for 30 minutes followed by 
99°C for 5 minutes to inactivate MultiScribe-RT. PCR of 
cDNA was carried out in a 50 μL reaction volume contain-
ing 1 × RT-PCR buffer, 1.75 mM MgCl2, 0.8 mM dNTPs, 
2.5 U AmpliTaq Gold DNA polymerase (Applied Bio-
systems), 2 pmols of D1 primer, on a ABI 9700 PCR ther-
mal cycler. The thermal profile consisted of an initial 
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denaturation step at 95°C for 10 minutes, followed by 35 
cycles of 95°C for 30 seconds, 55°C for 30 seconds, 72°C 
for 1 minute and a final extension at 72°C for 10 minutes. 
The PCR products were gel purified from 1.2% (w/v) agar-
ose gels using the Accu-Prep Gel Extraction Kit (Bioneer, 
USA). Positive samples were selected for automated nucle-
otide sequencing.
Automated nucleotide sequencing
Thirty amplified products from RT-PCR positive samples, 
from 2003–07, were subjected to automated nucleotide 
sequencing. Sequencing was carried out using Big dye-
terminator cycle sequencing ready reaction kit (Applied 
Biosystems). For each sequencing reaction approximately 
25 ng of purified PCR product was mixed with 3.2 pM 
of respective primer (D1 or D2) and a reaction mixture 
containing AmpliTaq DNA polymerase and four dye-
labeled di-deoxy nucleotide terminators. The reaction was 
placed onto a pre-heated thermal cycler. Cycle sequencing 
parameters consisted of 25 cycles at 96°C for 10 seconds, 
50°C for 5 seconds and 60°C for 4 minutes. The reaction 
mixture was purified by precipitation with 3 M Sodium 
acetate (pH 4.6) and 75% isopropanol and the product 
vacuum dried. The DNA pellet was re-suspended in 10 μL 
of template suppression reagent, heated at 95°C for 
2 minutes and immediately chilled on ice, then mixed and 
briefly centrifuged before loading onto an ABI 310 auto-
mated capillary DNA sequencer (Applied Biosystems).
Database submission
Thirty DENV-3 CprM sequences were determined in this 
study, submitted to GenBank at www.ncbi.nlm.nih.gov, 
and accession numbers acquired. Prior to this, BLAST 
searches were carried out to confirm the virus type. See 
Table 1 for a description of these viruses. An intermediate 
region of 425 bp was selected for multiple sequence 
alignment.
Sequences comparison
Thirty seven previously reported DENV-3 CprM sequences 
from different geographical locations (South-East Asia, 
Africa, Americas) and nine sequences from India were re-
trieved from the National Center for Biotechnology 
Information database (Table 2) and selected for com-
parison with the 30 DENV-3 sequences from this study. 
Sequences are designated by the country of isolation and 
the last two digits from the year of isolation, and identi-
fied by virus identity.
Multiple sequence alignment
Nucleotide sequences from sense and anti-sense strands 
were aligned using Sequence Navigator software. Multiple 
sequence alignment was performed using BioEdit soft-
ware version 7 employing the Clustal W multiple alignment 
option.23,24 These nucleotide sequences were translated 
into amino acid sequences for comparison with other 
Indian and globally submitted sequences. The Lasergene 
5 software package (DNASTAR Inc, Madison, WI, USA) 
was used to examine the percent identity and diversity 
among sequences.
Phylogenetic tree
Phylogenetic analysis was carried out using MEGA ver-
sion 3.1.25 A phylogenetic tree was constructed employing 
the Neighbor Joining method26 with bootstrap analysis 
of 1000 replicates. The tree was rooted using DENV-1, 
DENV-2 and DENV-4 CprM sequences (GenBank acces-
sion numbers NC_001477, NC_001474, and NC_002640, 
respectively).
Results
A total of 30 DENV-3 isolates from 2003–07 (4 from 2003, 
9 from 2005, 14 from 2006 and 3 from 2007) were con-
firmed by RT-PCR, partial nucleotide sequencing and 
Blast analysis in this study. CprM sequences of these 30 
DENV-3 isolates from Delhi were submitted to GenBank 
and accession numbers obtained (Table 1). An intermedi-
ate region of 425 bp from these sequences were aligned 
(nt 186–610) with nine previously reported Indian se-
quences and 37 previously reported sequences globally. 
Sequence alignment revealed only nucleotide substitu-
tions, with no insertions or deletions apparent. This re-
gion was found to be AT rich with the AT composition 
of the 30 DENV-3 sequences in this found to vary from 
52.07–54.15%. The majority of mutations observed in the 
Indian DENV-3 CprM sequences were transitions that 
were mostly synonymous in nature. All the Indian se-
quences, except for one from Gwalior isolated in 2003 
(GWL-60), exhibited a mean sequence identity of 98% 
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 Table 1. Indian DENV-3 isolates sequenced in this study
Virus isolate namea
 Date of collection 
Age (yr) Sex GenBank accession no. Pathology
 (dd/mm/yr)
India 03 04DEL03 09.10.03 30 F AY706096 DHF (grade II)
India 03 10DEL03 26.10.03 15 M AY706097 DF
India 03 11DEL03 26.10.03 14 F AY706098 DF
India 03 19DEL03 30.10.03 40 M AY706099 DF
India 05 01DEN05 28.09.05 26 F DQ645945 DF
India 05 02DEN05 28.09.05 19 M DQ645946 DF
India 05 03DEN05 28.09.05 25 M DQ645947 DF
India 05 04DEN05 02.10.05 20 F DQ645948 DHF (grade II)
India 05 05DEN05 02.10.05 21 M DQ645949 DF
India 05 06DEN05 02.10.05 27 M DQ645950 DF
India 05 07DEN05 02.10.05 23 M DQ645951 DF
India 05 08DEN05 06.10.05 31 M DQ841951 DF
India 05 09DEN05 06.10.05 17 M DQ841952 DF
India 06 15/3/del2006 10.10.06 5 F EU181201 DF
India 06 16/3/del2006 10.10.06 37 M EU181202 DF
India 06 17/3/del2006 10.10.06 6 F EU181203 DF
India 06 18/3/del2006 17.10.06 9 M EU181204 DHF (grade III)
India 06 19/3/del2006 17.10.06 10 F EU181205 DF
India 06 20/3/del2006 17.10.06 45 F EU181206 DF
India 06 21/3/del2006 17.10.06 26 M EU181207 DF
India 06 22/3/del2006 23.10.06 8 M EU181208 DF
India 06 23/3/del2006 23.10.06 54 F EU181209 DF
India 06 24/3/del2006 23.10.06 13 M EU181210 DHF (grade III)
India 06 25/3/del2006 26.10.06 14 F EU181211 DF
India 06 26/3/del2006 26.10.06 22 M EU181212 DF
India 06 27/3/del2006 26.10.06 49 F EU181213 DF
India 06 28/3/del2006 26.10.06 17 M EU181214 DF
India 07 D3/1CprM/Del07 09.10.07 26 M EU846234 DF
India 07 D3/2CprM/Del07 09.10.07 33 M EU846235 DF
India 07 D3/3CprM/Del07 17.10.07 41 F EU846236 DF
aDesignated by country of isolation and the last two digits of the year of isolation, followed by virus ID. DF = dengue fever; DHF = dengue 
hemorrhagic fever.
with Guatemala 98, and 98.45% with Martinique 01 and 
Puerto Rico 00 sequences. GWL-60 was divergent from 
other Indian sequences and demonstrated sequence iden-
tity of 98.6–99.3% with the Sri Lanka 98, Martinique 00, 
Guatemala 97, Mexico 96 and Nicaragua 98 sequences. 
When the GWL-60 sequence was compared with other 
Indian sequences, seven nucleotide substitutions were ob-
served. Four T > C transitions at nucleotide positions 203, 
256, 271 and 289; two C > T transitions at positions 206 
and 295; and a single G > A transition at position 265 
could be seen. None of these nucleotide substitutions 
gave rise to any amino acid changes. A year by year analy-
sis of Indian DENV-3 sequences revealed that Guatemala 
98, Martinique 01 and Puerto Rico 00 exhibited a mean 
sequence identity of 98.25% with the 2003 sequences, 
97.75% with 2004 sequences, 98.6% with 2005 sequences, 
97.5% with 2006 sequences and 97.75% with 2007 se-
quences. All Indian sequences showed a sequence diver-
gence of 0.2–3.4% amongst themselves, with a mean 
year-wise divergence of 1.20–1.65%. In the 2003 and 2004 
Indian sequences a “T” was present at nucleotide position 
358. This was replaced by a “C” residue in all Indian 
 57
Molecular epidemiology of DENV-3 in Delhi
Table 2. Indian and global DENV-3 reference sequences used for comparison in this study
Sequence namea Genotype GenBank accession no.
Philippines 56 H-87 I M93130
India 03 strain DEL-12 III AY770513
India 03 strain GWL-25 III AY770511
India 03 strain GWL-60 III AY770512
India 04 04DEL61 III DQ323037
India 04 04DEL75 III DQ323038
India 04 04DEL135 III DQ323039
India 04 04DEL139 III DQ323040
India 04 04DEL170 III DQ323041
India 04 04DEL171 III DQ323042
Sri Lanka 84 D1440 III AF547229
Mozambique 85 D3Moza85 III AY665402
Indonesia 88 den3_88 I AY858038
Sri Lanka 89 D2803 III AF547232
Kenya 91 251991 III AF547239
Somalia 93 SOM079 III AF547240
Malaysia 94 Z026 II AB010990
Sri Lanka 94 D9397 III AF547235
Mexico 96 BC184/97 III AF547252
Philippines 97 PhMH-J1-97 I AY496879
Guatemala 97 GUATE97-5 III AB038473
Sri Lanka 98 K1 III AF547243
Guatemala 98 GUATE98-5 III AB038478
Nicaragua 98 7071 III AF547262
Indonesia 98 98902890 DF DV-3 I AB189128
Indonesia 98 den3_98 I AY858039
Thailand 98 KPS-4-0657/207 II AY912458
Martinique 00 H/IMTSSA/1706 III AY099339
Puerto Rico 00 400-996 III AF547264
Martinique 01 H/IMTSSA/2012 III AY099340
Brazil 02 BR74886/02  III AY679147
Venezuela 03 3 VEN03 III AF547261
Indonesia 04 TB55i I AY858048
Indonesia 04 TB16 I AY858047
Indonesia 04 PH86 I AY858045
Indonesia 04 KJ71 I AY858044
Indonesia 04 FW01 I AY858040
Indonesia 04 BA51 I AY858037
Singapore 04 D3/SG/SS710/2004 III EU081181
Singapore 05 D3/SG/05K791DK1/2005 III EU081182
Singapore 05 D3/SG/05K805DK1/2005 III EU081185
Singapore 05 D3/SG/05K2418DK1/2005 III EU081195
Singapore 05 D3/SG/05K4159DK1/2005 III EU081217
Singapore 05 D3/SG/05K3312DK1/2005 III EU081200
Singapore 05 D3/SG/05K3325DK1/2005 III EU081204
Singapore 05 D3/SG/05K3927DK1/2005 III EU081212
aDesignated by country of isolation and the last two digits of year of isolation, followed by virus ID.
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sequences isolated after 2005. The transition at this posi-
tion did not produce any amino acid changes in the 
deduced amino acid alignment. Nucleotide changes were 
also observed in virus sequences from each year, with 2003 
and 2004 sequences exhibiting a lower number of muta-
tions than sequences from 2005–07. Although the 2006 
sequences, 27/3/del2006 and 28/3/del2006 contained 
two G > C transversions (nucleotide positions 281 and 
554), one A > C transversion (nucleotide position 555) and 
1 A > G transition (nucleotide position 564); only 2 G > C 
transversions gave rise to two amino acid changes, alanine 
to proline and aspartate to proline at amino acid posi-
tions 63 and 154, respectively. The isolate D3/1CprM/
Del07 contained a single A > C transversion at nucleotide 
position 197, resulting in an amino acid change at posi-
tion 35 where lysine was replaced by glutamine. However, 
in sequences D3/2CprM/Del07 and D3/3CprM/Del07, 
two nucleotide substitutions, A > G and C > T at nucle-
otide positions 277 and 307, did not result in any amino 
acid changes.
A phylogenetic tree was constructed using pair-wise 
comparison of a 425 nt region from the CprM junction (nt 
186–610) of virus isolates sequenced in this study and 
from other countries including Asia, Africa and Americas 
(Figure). The phylogenetic tree demonstrated that all 
DENV-3 isolates were clustered in three distinct geno-
types with all Indian DENV-3 isolates from 2003–07 clas-
sified as genotype III yet divergent as a distinct Indian 
lineage. This lineage shows a close relationship to the 
Guatemala 98, Puerto Rico 00 and Martinique 01 isolates. 
The 2003 Indian isolate, GWL-60, tended to cluster with 
viruses from Sri Lanka, Martinique, Nicaragua, Mexico and 
Guatemala isolated from 1996–2000. Genotype III consisted 
of viruses from various regions of the world such as the 
Americas, Africa and South-East Asia. DENV-3 strains from 
Africa (Mozambique 85, Kenya 91 and Somalia 93) clustered 
together forming a separate group within genotype III. 
Similarly, strains from Singapore isolated in 2004 and 
2005 could also be grouped together with the Brazil 02, 
Venezuela 03 and Sri Lanka 84 isolates. Other viruses 
amongst this genotype did not show geographical clustering.
The oldest virus strain, H-87, isolated from the 
Philippines in 1956 was classified as genotype I clustering 
with viruses from Indonesia and Philippines isolated from 
1988–2004. Genotype II consisted of two viruses from 
Thailand and Malaysia isolated in 1998 and 1994, respec-
tively. Due to the unavailability of the DENV-3 genotype 
IV CprM sequences we could not include these while 
constructing the phylogenetic tree.
Discussion
Outbreaks of dengue and dengue hemorrhagic fever have 
been reported from almost all tropical and sub-tropical 
regions of the world. This is probably due to the signifi-
cant increase in human and mosquito populations cour-
tesy of rapid urbanization and increased frequency of 
long-distance travel by humans.27 Although DHF has 
been endemic in India, four known serotypes have been 
implicated in various outbreaks in the past,4,14–16,28 with 
most major and severe outbreaks of DF/DHF having been 
caused by DENV-2. In 2003, there was a noticeable shift in 
the cause of these outbreaks from DENV-2 to DENV-3.14,15 
From 2003 onwards, DENV-3 has been found to be 
the predominant dengue virus circulating in Delhi,14–16 
however DENV-1 was also reported to circulating from 
2006.16,17
In this study we carried out a molecular epidemiologi-
cal study of DENV-3 that has been circulating in Delhi 
since its re-emergence in 2003, using sequence compari-
son and phylogenetic analysis. Genotypic identification 
has proven to be a useful tool for determining the origin 
and spread of epidemics and in correlating virulence of 
strains.29 Various genomic regions of dengue viruses have 
been selected by researchers for molecular phylogenetic 
analysis in the past.4,18,30,31 Although the dengue virus ge-
nome has three major structural genes, known as the cap-
sid, pre-membrane and envelope genes, along with seven 
non-structural genes, many studies have reported the 
CprM junction as a powerful target in genotyping.15,16,21,22 
The CprM junction was found to harbor epidemiologi-
cally important sequence information with a single pair 
of primers able to be used for amplification and sequenc-
ing of any of the four dengue virus serotypes. For phyloge-
netic analysis of our sequences, we retrieved previously 
reported sequences of the same region from the National 
Centre for Biotechnology Information GenBank database.
Analysis of Indian DENV-3 sequences revealed fea-
tures that are characteristic of the CprM junction. It was 
found that most of the mutations in our sequences were 
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India 05 05DEN0564
India 05 06DEN05
India 05 01DEN05
India 06 20/3/del2006
India 06 21/3/del2006
India 05 07DEN05
India 06 24/3/del2006
India 05 08DEN05
India 07 D3/2CprM/Del07
India 07 D3/3CprM/Del07
India 05 09DEN05
India 05 04DEN05
India 03 04DEL03
India 03 19DEL03
India 03 10DEL03
India 04 04DEL170
India 04 04DEL139
India 04 04DEL75
India 04 04DEL171
India 04 04DEL135
India 03 strain DEL-12
India 03 strain GWL-25
India 04 04DEL61
India 03 11DEL03
Somalia 93 SOM079
Kenya 91 251991
Gautemala 98 GUATE98-5
Puerto Rico 00 400-996
Martinque 01 H/IMTSSA/2012
Mexico 96 BC184/97
Guatemala 97 GUATE97-5
Nicargua 98 7071
Martinque 00 H/IMTSSA/1706
Mozambique 85 D3Moza85
Sri Lanka 89 D2803
VeneZuela 03 3 VEN03
Brazil 02 BR74886/02
Singapore 04 D3/SG/SS710/2004
Singapore 05 D3/SG/05K4159DK1/2005
Singapore 05 D3/SG/05K3312DK1/2005
Singapore 05 D3/SG/05K3325DK1/2005
Singapore 05 D3/SG/05K791DK1/2005
Singapore 05 D3/SG/05k2418DK1/2005
Singapore 05 D3/SG/05K805DK1/2005
Singapore 05 D3/SG/05K3927DK1/2005
Philippines 56 H-87
Phillippines 97 PhMH-J1-97
Indonesia 98 98902890 DF DV-3
Indonesia 88 den3 88
Indonesia 04 FW01
Indonesia 04 BA51
Indonesia 98 den3 98
Indonesia 04 TB55i
Malaysia 94 Z026
Thailand  98 KPS-4-0657/207
DENV1 NC 001477
DENV2 NC 001474
DENV4 NC 002640
Indonesia 04 TB16
Indonesia 04 KJ71
Indonesia 04 PH86
Sri Lanka 94 D9397
Sri Lanka 84 D1440
Sri Lanka 98 K1
India 03 strain GWL-60
India 05 02DEN05
India 06 17/3/del2006
India 06 18/3/del2006
India 07 D3/1CprM/Del07
India 06 15/3/del2006
India 06 25/3/del2006
India 05 03DEN05
India 06 16/3/del2006
India 06 19/3/del2006
India 06 22/3/del2006
India 06 23/3/del2006
India 06 26/3/del2006
India 06 27/3/del2006
India 06 28/3/del2006
63
99
88
92
51
56
56
96
50
64
89
55
65
84
50
98
99
50
70
80
76
77
77
64
62
98
99
0.05
Genotype II
Genotype I
Genotype III
Indian lineage
Figure. Phylogenetic tree of DENV-3. The tree was generated based on a 425 bp region of the CprM gene junction. Each isolate was 
designated by country of isolation and the last two digits of year of isolation, followed by the virus ID. Bootstrap support values 
(≥ 50%) are shown for major nodes on the tree. All horizontal branch lengths are drawn to scale. DENV-3 sequences of the present 
study are denoted in bold and Indian sequences used for comparison in bold italics.
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silent and that the region examined was AT rich, hence 
more prone to mutations. The hydrophilic amino acids 
were mostly found on the surface of the protein and 
thought to be involved in immunological interactions. 
A number of amino acid changes were observed in the 
2006 and 2007 sequences where non-polar alanine was re-
placed by polar proline and positively charged lysine 
replaced by uncharged glutamine. These changes might 
not be very significant in terms of antigenicity as the hy-
dropathy index did not show any major differences.32 
However, another amino acid change from negatively 
charged aspartate to non-polar proline also occurred in 
these isolates. The implications of unique changes in re-
cent Indian DENV-3 warrant further studies to under-
stand their virulence and epidemic potential. The 2006 
and 2007 Delhi isolates exhibiting amino acid changes 
were isolated from DF patients and no specific amino acid 
substitution could be identified with a severe form of 
disease. It is noteworthy to mention that the four Indian 
isolates from this study causing DHF in patients (Table 1) 
did not exhibit any common nucleotide or amino acid 
substitutions but when compared with the amino acid se-
quences of DENV-3 causing DF they showed identical 
results. No significant correlation was seen between the 
CprM sequences and differences in clinical severity, con-
firming the absence of any known virulence marker in this 
region.
The phylogenetic tree classified all 76 DENV-3 se-
quences into their respective subtypes/genotypes as desig-
nated by Lanciotti et al.18 All 30 Indian isolates belonged 
to genotype III along with other geographically diverse 
strains. However, they clustered as a distinct Indian line-
age, thereby suggesting independent evolution of these 
viruses. Indian isolates from this lineage were found to be 
closely related to a Central American isolate, Guatemala 
98 (Guate 98-5), suggesting this virus to be the progenitor 
for this lineage. A single Indian isolate, India 03 GWL60, 
was classified into another group suggesting and alterna-
tive origin from the other Indian strains. This study con-
firms previous reports that circulating Indian DENV-3 
strains are related to strains that caused dengue outbreaks 
in Guatemala and Martinique in the 1990s.33
The oldest DENV-3 strain, Philippines 56, was classi-
fied as genotype I along with other strains from the 
Philippines and Indonesia isolated over two decades, 
suggesting the persistence of this genotype in the area for 
a long time.
It is evident that genotype III of DENV-3 circulates 
throughout the world, whereas other genotypes are 
localized in particular geographic regions. This indicates 
a higher potential of genotype III to spread and dominate 
in geographically diverse regions of the world. This 
genotype has also been implicated in major dengue epi-
demics in several parts of Asia, Africa and the Americas 
and has the potential to cause an international dengue 
pandemic.34
The findings of this study indicate independent evolu-
tion of DENV-3 leading to emergence of a distinct Indian 
lineage within genotype III since 2003. Since similar 
strains of DENV-3 genotype III have been reported to 
cause major outbreaks in Asia and other parts of the 
world, continued surveillance is warranted to monitor the 
incursion and spread of this virus so that timely and effec-
tive control strategies can be instituted before the onset of 
the next outbreak.
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